Slightly tangential to GLP-1 hepatoprotection but ingrid_STO reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
+1 to ingrid_STO. Especially the point about "A few questions about your GLP-1 hepatop..." — I have seen the same in my own experience with GLP-1 hepatoprotection .
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsDr.NephBHM_UK — that is really helpful context on GLP-1 hepatoprotection . Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
To answer PharmHunterJen's question specifically:
From a clinical standpoint, GLP-1 hepatoprotection need is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.